Rare diseases
Investigational molecules
Locations
Study of inavolisib, ribociclib, and fulvestrant for patients with advanced hormone-receptor-positive, HER2-negative breast cancer.
PolandA study of YL201 and atezolizumab for patients with advanced solid tumors
PolandComparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma
PolandA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
PolandA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
PolandA study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer
PolandStudy of Revumenib, Cytarabine, and Fludarabine in Children with Relapsed or Refractory Acute Myeloid Leukemia
PolandA study to evaluate the safety and effects of inebilizumab in children and adolescents with immunoglobulin G4-related disease
PolandA study comparing AZD0486 after reduced chemotherapy versus standard chemotherapy in older or unfit patients with newly diagnosed large B-cell lymphoma
PolandA study testing the safety and effectiveness of BP1.
PolandA study of finerenone with standard treatment for children and young adults from birth to 18 years with heart failure and left ventricular systolic dysfunction
PolandA study of finerenone added to standard treatment in children aged 6 months to under 18 years with heart failure and reduced left heart pumping function
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
